What Are Irradiated PBMC? Learn About Our Newest Product.

Sometimes researchers need access to the components and benefits of normal peripheral blood mononuclear cells, but don’t want the cells to proliferate in their experiments. That’s where irradiated PBMC come in handy. Learn more about our newest immune cell product below. What Are Irradiated PBMC? Irradiated PBMC are normal PBMC that have been exposed to…

Read more

What We Learned at AACR 2019

We all know that CAR-T therapies and immune checkpoint inhibitors are game-changers for oncology, and both were on display at the American Association for Cancer Research’s annual meeting held in Atlanta last week. Although both therapies have produced spectacular results in some patients, neither work for all patients and efforts must now turn to understanding…

Read more

Ask A Scientist: Immunology Acronym Confusion

With so many acronyms used in the field of immunology, things can get confusing and mistakes can be costly. Acronyms are useful devices to reduce long, sometimes tongue-twisting terms into manageable shorthand, but do add confusion to those newer to the field.    We’ve cleared up several of these situations through the years via our…

Read more

New Resource for Antigen-Specific T Cells

Antigen-specific T cells are a powerful tool for understanding human immunity and developing treatments and cures for our most prolific diseases. Luckily, they are more readily available to researchers than ever before. Not only have we devoted many resources over the past several years to developing an exclusive inventory of antigen-specific T cells for use…

Read more

AACR 2019 Restaurant Guide: Atlanta

We are headed to the American Association for Cancer Research’s 2019 annual meeting in Atlanta! We will be at the show from March 31 – April 3 in booth #4907 to answer your immunology research questions and highlight our latest immune cell developments. If you will be in Atlanta for AACR, save this list of…

Read more
cancer patients

Patient Power: Fighting Back Through Research Participation

Cancer Patients Give Blood Cells to Advance Treatment Studies Cancer patients are fighting back and helping advance the development of cutting edge cancer treatments by giving blood cells for laboratory medical research. Patients giving small amounts of white blood cells allow preclinical scientists to study the potential effectiveness and critical safety of innovative immune treatments.…

Read more

Ask A Scientist: Progenitor vs. CD34+ Cells

Progenitor cells and CD34+ cells are often referred to interchangeably as stem cells. While this oversimplification is technically correct, there are many distinctions between the origins, functions, and uses of progenitor cells and CD34+ cells. What is the Difference Between Progenitor and CD34+ Cells? Despite their many similarities, the most significant difference between the two…

Read more